Ibogaine Hydrochloride (HCl) – Chemical Reference Profile

Ibogaine hydrochloride is the hydrochloride salt form of ibogaine, a naturally occurring indole alkaloid.

According to PubChem, ibogaine hydrochloride has the molecular formula C20H27ClN2O and a calculated molecular weight of approximately 346.9 g/mol. PubChem identifies it as a compound consisting of ibogaine associated with hydrochloric acid. PubChem

Additionally, the hydrochloride form is commonly described in chemical databases using names such as ibogaine HCl, ibogaine monohydrochloride, and ibogaine hydrochloride.

This page is presented for chemical identification, documentation and analytical reference. It does not provide instructions for administration, preparation or procurement.

Ibogaine Hydrochloride Overview

Ibogaine hydrochloride is chemically related to the parent compound ibogaine.

Unlike raw botanical material, the hydrochloride designation refers to a defined salt form of the alkaloid. Therefore, chemical records should clearly distinguish between ibogaine free base and ibogaine hydrochloride.

Important reference information may include:

• Chemical name
• Common synonyms
• Molecular formula
• Molecular weight
• PubChem identifier
• Physical form
• Batch identifier
• Analytical method
• Certificate of analysis, when applicable
• Storage information
• Regulatory classification

Furthermore, any purity statement should correspond to an actual batch-specific analytical report rather than a general marketing claim.

For other agricultural and botanical reference information, visit the AfriqAgro marketplace.

Chemical Identity of Ibogaine Hydrochloride

The compound is commonly identified as ibogaine hydrochloride or ibogaine HCl.

PubChem currently records:

• Compound: Ibogaine hydrochloride
• PubChem CID: 197059
• Molecular formula: C20H27ClN2O
• Molecular weight: approximately 346.9 g/mol
• Parent compound: Ibogaine
• Parent-compound PubChem CID: 197060

In addition, PubChem lists 5934-55-4 among the identifiers associated with its ibogaine hydrochloride record. PubChem

Because chemical identifiers can vary between databases, labels and historical records, the identifier used on a commercial laboratory document should always be checked against the corresponding certificate of analysis and supplier documentation.

Ibogaine and Ibogaine HCl

Ibogaine itself has the molecular formula C20H26N2O and PubChem CID 197060. The hydrochloride form incorporates hydrochloride into the corresponding salt record. PubChem

Consequently, the two names should not be treated as interchangeable when recording molecular weight, chemical formula or analytical documentation.

For authoritative chemical information, consult the PubChem record for ibogaine hydrochloride.

Analytical Documentation

For scientific reference materials, analytical documentation is particularly important.

A complete record may include:

• Batch or lot number
• Analytical method
• Assay result
• Date of analysis
• Laboratory name
• Sample identification
• Chromatographic documentation where applicable
• Certificate of analysis
• Storage conditions

For example, if a listing states “98% purity”, that figure should come from a valid analysis of the specific batch.

Therefore, avoid automatically describing every batch as 98%+, HPLC verified, pharmaceutical grade, research grade, certified pure, or contaminant free unless the appropriate documentation actually supports the statement.

Physical Description

Ibogaine hydrochloride is represented in chemical databases as a defined hydrochloride salt.

However, physical appearance can vary depending on preparation, purity and storage conditions. Consequently, the actual appearance of a reference sample should be documented from the specific material rather than assumed from generic descriptions.

Useful documentation may include:

• Solid or powder form
• Observed color
• Batch weight
• Container type
• Packaging date
• Storage conditions

Moreover, photographs of individual reference samples should accurately represent the actual batch.

Safety Considerations

Ibogaine is a pharmacologically active psychoactive compound rather than an inert botanical material.

Scientific literature has associated ibogaine exposure with QT-interval prolongation and potentially serious ventricular arrhythmias. Recent medical literature continues to identify cardiovascular toxicity as an important safety concern. PubMed

Because of these risks, this page should not make claims suggesting that ibogaine hydrochloride is inherently safe, suitable for self-administration or appropriate for unsupervised therapeutic use.

Additionally, avoid treatment claims unless they are specifically permitted and supported under the laws governing the relevant jurisdiction.

Regulatory Considerations

The legal status of ibogaine varies internationally.

For example, ibogaine is classified as a Schedule I controlled substance in the United States. The DEA describes Schedule I substances as having no currently accepted medical use in the United States and a high potential for abuse under federal law. DEA

Therefore, a global website should not state that ibogaine HCl can be legally shipped worldwide.

Instead, regulatory information should make clear that applicable laws vary by destination and may change over time.

Responsible Chemical Documentation

Accurate documentation should take priority over promotional claims.

For that reason, scientific reference listings should identify the substance clearly and distinguish verified facts from supplier-specific claims.

Where analytical testing is available, provide the actual supporting documentation. Likewise, if no current certificate of analysis is available, avoid presenting an assumed purity percentage as fact.

This approach improves both transparency and the reliability of the page.

Storage and Handling Information

Chemical-reference materials should be stored according to the instructions supplied with the applicable analytical documentation or safety data.

In general, the product label should state the exact storage conditions supported by the supplier or laboratory documentation.

Furthermore, containers should be clearly labelled with relevant identification information such as:

• Chemical name
• Batch number
• Date
• Net quantity
• Relevant hazard information
• Storage requirements

This reduces confusion between ibogaine hydrochloride and other botanical or chemical materials.

Ibogaine Hydrochloride Technical Summary

Overall, ibogaine hydrochloride is the hydrochloride salt form of the psychoactive alkaloid ibogaine.

Its established chemical record includes the formula C20H27ClN2O, a molecular weight of approximately 346.9 g/mol, and PubChem CID 197059. PubChem

Furthermore, the compound should be documented with particular care because its pharmacological activity, safety profile and legal status differ substantially from those of ordinary botanical specimens.

For authoritative chemical identification, consult PubChem – Ibogaine Hydrochloride.

Ibogaine Hydrochloride Key Specifications

• Chemical name: Ibogaine hydrochloride
• Common abbreviation: Ibogaine HCl
• Compound type: Hydrochloride salt
• Parent compound: Ibogaine
• Molecular formula: C20H27ClN2O
• Molecular weight: Approximately 346.9 g/mol
• PubChem CID: 197059
• Parent ibogaine CID: 197060
• Referenced identifier in PubChem: 5934-55-4
• Chemical family: Indole alkaloid derivative
• Reference format: Chemical/analytical reference
• Purity: Use actual batch-specific analytical result
• Batch identification: Recommended
• Certificate of analysis: Recommended when analytical claims are made
• Storage: Follow batch documentation/SDS
• Regulatory status: Jurisdiction dependent

The molecular formula, molecular weight and PubChem identifiers above are based on PubChem’s current chemical records.